Transferrin receptor-dependent and -independent iron transport in gallium-resistant human lymphoid leukemic cells

Blood

Volumn 91, Issue 12, 1998, Pages 4686-4693

  Chitambar, Christopher R ^a   Wereley, Janine P ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM NITRATE; IRON 59; PYRIDOXAL ISONICOTINOYLHYDRAZONE; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ARTICLE; CONTROLLED STUDY; EXOCYTOSIS; HUMAN; HUMAN CELL; IRON KINETICS; IRON TRANSPORT; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031811699     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.12.4686.412k15_4686_4693     Document Type: Article

References (41)

1. Warrell RP, Jr: Clinical trials of gallium nitrate in patients with cancer-related hypercalcemia. Semin Oncol 18:26, 1991
2. Foster BJ, Clagett-Carr K, Hoth D, Leyland-Jones B: Gallium nitrate: The second metal with clinical activity. Cancer Treat Rep 70:1311, 1988
3. Seligman PA, Crawford ED: Treatment of advanced transitional cell carcinoma of the bladder with continuous infusion gallium nitrate. J Natl Cancer Inst 83:1582, 1991
4. Crawford ED, Saiers JH, Baker LH, Costanzi JH, Bukowski RM: Gallium nitrate in advanced bladder carcinoma: Southwest Oncology Group study. Urology 38:355, 1991
5. Seidman AD. Scher HI, Heinemann MH, Bajorin DF, Sternberg CN, Dershaw DD, Silverberg Mt Bosl GJ: Continuous infusion gallium nitrate for patients with advanced refractory urothelial tumors. Cancer 68:2561, 1991
6. Keller J, Bartolucci A, Carpenter JT, Jr, Feagler J: Phase II evaluation of bolus gallium nitrate in lymphoproliferative disorders: A Southeastern Cancer Study Group trial. Cancer Treat Rep 70:1221, 1986
7. Weick JK, Stephens RL, Baker LH, Jones SE: Gallium nitrate in malignant lymphoma: A Southwest Oncology Group study. Cancer Treat Rep 67:823, 1983
8. Warrell RP, Jr, Coonley CJ, Straus DJ, Young CW: Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a seven-day continuous infusion. Cancer 51:1982, 1983
9. Chitambar CR, Seligman PA: Effects of different transferrin forms on transferrin receptor expression, iron uptake and cellular proliferation of human leukemic HL60 cells: Mechanisms responsible for the specific cytotoxicity of transferrin-gallium. J Clin Invest 78:1538, 1986
10. Chitambar CR, Matthaeus WG, Antholine WE, Graff K, O'Brien WJ: Inhibition of leukemic HL60 cell growth by transferrin-gallium: Effects on ribonucleotide reductase and demonstration of drug synergy with hydroxyurea. Blood 72:1930, 1988
11. Chitambar CR. Narasimhan J, Guy J, Sem DS, O'Brien WJ: Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells. Cancer Res 51:6199, 1991
12. Chitambar CR, Wereley JP: Resistance to the antitumor agent gallium nitrate in human leukemic cells is associated with decreased gallium/iron uptake, increased activity of iron regulatory protein-1, and decreased ferritin production. J Biol Chem 272:12151, 1997
13. Harris WR, Pecoraro VL: Thermodynamic binding constants for gallium transferrin. Biochemistry 22:292, 1983
14. 59Fe uptake by cultured mouse myeloma cells. Cancer Res 37:3634, 1977
15. Larson SM, Rasey JS, Allen DR, Nelson NJ, Grunbaum Z, Harp GD, Williams DL: Common pathway for tumor cell uptake of Gallium-67 and Iron-59 via a transferrin receptor. J Natl Cancer Inst 64:41, 1980
16. Chitambar CR, Zivkovic Z: Uptake of gallium-67 by human leukemic cells: Demonstration of transferrin receptor-dependent and transferrin-independent mechanisms. Cancer Res 47:3929, 1987
17. 67Ga by human leukemic HL60 cells. Cancer Res 50:1484, 1990
18. Klausner RD, van Renswoude J, Ashwell G, Kempf C, Schecter AN, Dean A, Bridges KR: Receptor-mediated endocytosis of transferrin in K562 cells. J Biol Chem 258:4715, 1983
19. Klausner RD, Ashwell G, van Renswoude J, Harford J, Bridges KR: Binding of apotransferrin to K562 cells: Explanation of the transferrin cycle. Proc Natl Acad Sci USA 80:2263, 1983
20. Richardson DR, Ponka P: The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim Biophys Acta 1331:1, 1997
21. Basset P, Quesneau Y, Zwiller J: Iron-induced L1210 cell growth: Evidence of a transferrin-independent iron transport. Cancer Res 46:1644, 1986
22. Sturrock A, Alexander J, Lamb J, Craven CM, Kaplan J: Characterization of a transferrin-independent uptake system for iron in HeLa cells. J Biol Chem 265:3139, 1990
23. Inman RS. Wessling-Resnick M: Characterization of transferrin-independent iron transport in K562 cells. J Biol Chem 268:8521, 1993
24. Seligman PA, Kovar J, Schleicher RB, Gelfand EW: Transferrinindependent iron uptake supports B lymphocyte growth. Blood 78:1526, 1991
25. Chitambar CR, Sax D: Regulatory effects of gallium on transferrin-independent iron uptake by human leukemic HL60 cells. Blood 80:505, 1992
26. Bates GW, Schlabach MR: The reaction of ferric salts with transferrin. J Biol Chem 248:3228, 1973
27. Hunter HM, Greenwood FC: Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194:495, 1962
28. Ponka P, Schulman HM, Wilczynska A: Ferric pyridoxal isonicotinoyl hydrazone can provide iron for heme synthesis in reticulocytes. Biochim Biophys Acta 718:151, 1982
29. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytoxicity assays. J Immmunol Methods 65:55, 1983
30. Chitambar CR, Massey EJ, Seligman PA: Regulation of transferrin receptor expression on human leukemic cells during proliferation and induction of differentiation. Effects of gallium and dimethylsulfoxide.J Clin Invest 72:1314, 1983
31. Scatchard G: The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660, 1949
32. Rutledge EA, Root BJ, Lucas JJ, Enns CA: Elimination of the O-linked glycosylation site at Thr 104 results in the generation of a soluble human-transferrin receptor. Blood 83:580, 1994
33. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
34. Taetle R, Castognola J, Mendelsohn J: Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies. Cancer Res 46:1759, 1986
35. Omary BM, Trowbridge IS: Biosynthesis of the human transferrin receptor in cultured cells. J Biol Chem 256:12888, 1981
36. Larrick JW. Cresswell P: Modulation of cell surface iron transferrin receptors by cellular density and state of activation. J Supramol Struct 11:579, 1979
37. Trowbridge IS, Omary MB: Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci USA 78:3039, 1981
38. Brissot P, Wright TL. Ma W, Weisiger RA: Efficient clearance of non-transferrin-bound iron by rat liver. J Clin Invest 76:1463, 1985
39. Kaplan J, Jordan I, Sturrock A: Regulation of the transferrinindependent iron transport system in cultured cells. J Biol Chem 266:2997, 1991
40. Olakanmi O, Stokes JB. Pathan S, Britigan BE: Polyvalent cationic metals induce the rate of transferrin-independent iron acquisition by HL-60 cells. J Biol Chem 272:2599, 1997
41. Landschulz W, Thesleff I, Ekblom P: A lipophilic iron chelator can replace transferrin as a stimulator of cell proliferation and differentiation. J Cell Biol 98:596, 1984